from Reuters: Health News https://reut.rs/2RcfIuD
Wednesday, December 26, 2018
Wednesday, December 26, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease in adults and children aged two years and above.

from Reuters: Health News https://reut.rs/2RcfIuD
from Reuters: Health News https://reut.rs/2RcfIuD
Related Posts:
LATEST HEALTH NEWSIn at least 15 countries C-section use exceeds 40 per cent, researchers said from Health https://ift.tt/2OUjfwA … Read More
LATEST HEALTH NEWSAbbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira. from Reuters: Health News https://if… Read More
LATEST HEALTH NEWSA New Jersey jury on Thursday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer. … Read More
LATEST HEALTH NEWSThe new research undercuts widely held beliefs about strenuous physical training and pregnancy from Health https://ift.tt/2pQAdhh … Read More
LATEST HEALTH NEWSThe relationship between the public and private healthcare systems in India is tenuous from Health https://ift.tt/2INyK3U … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment